VKTX

Viking TherapeuticsNASDAQ · StockSectorHealthcare IndustryBiotechnologyExchangeNASDAQ

$28.43−0.21 (−0.75%)US pre-market · opens in 4h 17m

At close

Free account:WatchlistPrice and earnings alertsTrade TalkNo trading account needed

Daily move−0.8%vs prev close $28.65

VolatilityVery highATR $1.72 · 6.0%

Gap %+0.5%Open vs prev close

52-week position24%of range $23.89–$43.08

Loading chart…

Why is VKTX moving?

Automated summary · updated 04:00 ET

VKTX is down 0.8% as of the last close. We found no company-specific news; that’s within its normal daily range.

NoteWithin its normal range

Built automatically from market data. Not investment advice.

Part of

Collections that include VKTX

ThemeWeight-loss drugs+2.0% today

IndustryBiotechnology0.0% today

SectorHealthcare+0.8% today

ExchangeNASDAQ-listed+2.5% today

Investor holdings

Held by 9 of 50 tracked investors13F · Q2 2026 · filed by Aug 14

1opened a position4added4trimmed

Two Sigma InvestmentsJohn Overdeck & David Siegel · Quant fund0.1%$154MTrimmed −11%D. E. ShawDavid E. Shaw · Quant fund0.0%$63MTrimmed −4%Citadel AdvisorsKen Griffin · Multi-strategy fund0.0%$37MTrimmed −25%Millennium ManagementIsrael Englander · Multi-strategy fund0.0%$19MAdded +99%Point72 Asset ManagementSteve Cohen · Multi-strategy fund0.0%$18MNew positionUS long positions only · filings lag the quarter end by up to 45 days · SEC EDGAR 13F · All tracked investors

Key stats

Stock

Open / Prev close: $28.79 / $28.65
Day range: $28.43 – $29.19
52-week range: $23.89 – $43.08
Volume: 117.4K
Market cap: $7B
ATR (14): $1.72 · 6.0% · Very high
Gap %: +0.5%
Industry today: Biotechnology 0.0%

SEC filings

All filings

Nov 5, 2026Amended: disclosed a passive stake of 5% or morePassive stake · SEC EDGAR13G/A Oct 28, 2026Quarterly report filedQuarterly report · SEC EDGAR10-Q Oct 28, 2026Reported results of operationsMaterial event · SEC EDGAR8-K Sep 28, 2026Entered a material agreement; Took on a material financial obligationMaterial event · SEC EDGAR8-K Sep 22, 2026Other eventsMaterial event · SEC EDGAR8-K Aug 7, 2026Insider trade reportedInsider trade · SEC EDGARForm 4

About Viking Therapeutics

Viking Therapeutics is listed on NASDAQ and belongs to the Biotechnology industry in the Healthcare sector.

Sector: Healthcare
Industry: Biotechnology
Market cap: $7B
Exchange: NASDAQ

VKTX FAQ

When is VKTX’s next earnings report?

Feb 9, 2027, after the close. Analysts expect EPS of $-1.32.

Why is VKTX stock moving today?

VKTX is down 0.8% as of the last close.

How volatile is VKTX?

VKTX’s average true range over 14 days is $1.72, 6.0% of its price. That puts it in our very high volatility class.

Best match for stocks

Put your VKTX edge to the test with Trade The Pool

Stock-specific funded accounts. Trade US equities like VKTX with firm capital and keep a share of the profits.